1. Insights into the Interplay between the Urinary Microbiome and Bladder Cancer: A Comprehensive Review
    Rigoberto Pallares-Mendez et al, 2024, Journal of Clinical Medicine CrossRef
  2. The interplay of extracellular matrix and microbiome in urothelial bladder cancer
    Massimo Alfano et al, 2016, Nature Reviews Urology CrossRef
  3. Fascin-1 and Its Role As a Serological Marker in Prostate Cancer: a Prospective case–control Study
    Octavian Sabin Tătaru et al, 2021, Future Science OA CrossRef
  4. CD147-induced cell proliferation is associated with Smad4 signal inhibition
    Hui Qin et al, 2017, Experimental Cell Research CrossRef
  5. Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis
    Tahereh Zeinali et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  6. The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?
    Naibin Zhang et al, 2023, Technology in Cancer Research & Treatment CrossRef
  7. Fascin and esophageal squamous cell carcinoma
    Yinwei Cheng et al, 2017, Precision Radiation Oncology CrossRef
  8. Fascin-1: Updated biological functions and therapeutic implications in cancer biology
    Chien-Hsiu Li et al, 2022, BBA Advances CrossRef
  9. Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer
    Mohammad Nabi Sanaee et al, 2015, Urologia Internationalis CrossRef
  10. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer
    Zhi Wang et al, 2021, BMC Cancer CrossRef
  11. CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis
    Hongru Li et al, 2017, Oncotarget CrossRef
  12. Expression of c-erb-B2 gene in bladder cancer of Egyptian patients and its correlation with p53 and bcl-2
    Saber A. Sakr et al, 2015, Biomedicine & Pharmacotherapy CrossRef
  13. Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?
    Hongliang Liu et al, 2021, Molecular Therapy - Oncolytics CrossRef